Announcement

Collapse
No announcement yet.

Treatments

Collapse
Forums Topics Posts Last Post
No forums found.
Mark Channels Read
  •  
  • Page of 1
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
Previous template Next
There are no conversations in this channel.
Previous template Next
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Page of 732
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Previous 1 41 91 131 141 151 191 241 641 732 template Next
Topics Statistics Last Post
Intern Emerg Med . Awake prone positioning for patients with COVID-19-related respiratory failure: a systematic review and meta-analysis by tetano
Started by tetano, October 6, 2023, 02:14 AM
0 responses
38 views
0 likes
 Last Post tetano
by tetano
October 6, 2023, 02:14 AM  
Infect Dis Ther . Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study by tetano
Started by tetano, October 6, 2023, 02:08 AM
0 responses
39 views
0 likes
 Last Post tetano
by tetano
October 6, 2023, 02:08 AM  
Stem Cell Res Ther . Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program by tetano
Started by tetano, October 6, 2023, 02:07 AM
0 responses
33 views
0 likes
 Last Post tetano
by tetano
October 6, 2023, 02:07 AM  
ASAIO J . Extracorporeal Membrane Oxygenation Support and Critically Ill COVID-19 Patient Outcomes: A Population-Based Cohort Study by tetano
Started by tetano, October 4, 2023, 01:51 AM
0 responses
19 views
0 likes
 Last Post tetano
by tetano
October 4, 2023, 01:51 AM  
J Allergy Clin Immunol Glob . ABX464 (obefazimod) for patients with COVID-19 at risk for severe disease: miR-AGE, a randomized, double-blind placebo-controlled trial by tetano
Started by tetano, October 3, 2023, 04:15 AM
0 responses
40 views
0 likes
 Last Post tetano
by tetano
October 3, 2023, 04:15 AM  
Nucleic Acid Ther . Highly Potent Antisense Oligonucleotides Locked Nucleic Acid Gapmers Targeting the SARS-CoV-2 RNA Genome by tetano
Started by tetano, October 3, 2023, 04:12 AM
0 responses
49 views
0 likes
 Last Post tetano
by tetano
October 3, 2023, 04:12 AM  
Eur J Pharm Sci . A First-In-Human Phase 1 Study of Simnotrelvir, a 3CL-like Protease Inhibitor for Treatment of COVID-19, in Healthy Adult Subjects by tetano
Started by tetano, October 3, 2023, 04:04 AM
0 responses
44 views
0 likes
 Last Post tetano
by tetano
October 3, 2023, 04:04 AM  
J Clin Virol . Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients by tetano
Started by tetano, October 2, 2023, 02:23 AM
0 responses
45 views
0 likes
 Last Post tetano
by tetano
October 2, 2023, 02:23 AM  
Chest . Do-Not-Resuscitate Orders by COVID-19 Status Throughout the First Year of the Coronavirus Disease 2019 Pandemic by tetano
Started by tetano, October 2, 2023, 02:20 AM
0 responses
42 views
0 likes
 Last Post tetano
by tetano
October 2, 2023, 02:20 AM  
J Virol . EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8 by tetano
Started by tetano, October 1, 2023, 02:09 AM
0 responses
35 views
0 likes
 Last Post tetano
by tetano
October 1, 2023, 02:09 AM  
Previous 1 41 91 131 141 151 191 241 641 732 template Next
No topics found.
Mark This Channel Read
  • Page of 0
  • Filter
  • Time
Clear All
Working...
X